Cargando…

OR29-04 TGFβ Regulates Bone Perilacunar/Canalicular Remodeling in a Sexually Dimorphic Manner

Sexual dimorphism in the material properties of bone extracellular matrix (ECM) and geometry, which are parameters of bone quality have been recognized (Alswat, 2017; Nieves et al., 2005). However, the molecular mechanisms responsible for dimorphic bone quality remain unclear, limiting our ability t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dole, Neha, Alliston, Tamara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Bone and Mineral Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209389/ http://dx.doi.org/10.1210/jendso/bvaa046.1975

Ejemplares similares

Glucocorticoids cause mandibular bone fragility and suppress osteocyte perilacunar-canalicular remodeling
por: Alemi, A. Sean, et al.
Publicado: (2018)

OR29-04 Vitamin D Signaling Prevents Glucocorticoid-Induced Musculoskeletal Tissue Loss And Cardiac Dysfunction By Targeting The Atrogene Pathway
por: Sato, Amy, et al.
Publicado: (2023)

OR13-04 Risk Of Wrist Fracture In Gastric Bypass Compared To Gastric Banding As Estimated By The Load-To-Strength Ratio
por: Jung, Grace H, et al.
Publicado: (2023)

OR29-02 Natural Language Processing of Radiology Reports Improves Identification of Patients with Fracture
por: Kolanu, Nithin, et al.
Publicado: (2020)

OR29-01 Deleting Salt Inducible Kinases In Osteoprogenitor Cells Increases Trabecular Bone
por: Papaioannou, Garyfallia, et al.
Publicado: (2023)

OR29-02 Energy Deficient Osteoblasts Inefficiently Mineralize Developing Bone In Sheep With Hypophosphatasia
por: Clarence Bertels, Joshua, et al.
Publicado: (2023)

OR13-3 Effects of Iron Isomaltoside versus Ferric Carboxymaltose on Hormonal Control of Phosphate Homeostasis: The PHOSPHARE-IDA04/05 Randomized Controlled Trials
por: Wolf, Myles, et al.
Publicado: (2019)

OR23-04 Treatment Of Chronic Hypoparathyroidism With Eneboparatide (AZP-3601), A Novel PTH 1 Receptor Agonist: Results From A Phase 2 Trial
por: Kamenicky, Peter, et al.
Publicado: (2023)

OR29-06 Burosumab Improves Biochemical, Skeletal, and Clinical Features of Tumor-Induced Osteomalacia Syndrome
por: Carpenter, Thomas O, et al.
Publicado: (2020)

OR29-05 A Natural History Study of Fibrodysplasia Ossificans Progressiva (FOP): 12-Month Outcomes
por: Mukaddam, Mona Al, et al.
Publicado: (2020)

OR29-07 A Novel Estimate of Creatinine Excretion to Determine Adequacy of 24-Hr Urine Collection
por: Kondapalli, Ananya V, et al.
Publicado: (2020)

OR29-06 Flare-Ups In Patients With Fibrodysplasia Ossificans Progressiva Reduced By Garetosmab Treatment: LUMINA-1 Data
por: Dahir, Kathryn M, et al.
Publicado: (2023)

OR07-04 A Novel Ex Vivo Live-Cell Interrogative Assay of Human Parathyroid Tissue Reveals Distinct Mechanisms of Calcium Sensing Failure in Primary, Secondary, and Tertiary Hyperparathyroidism
por: Zhang, Jie, et al.
Publicado: (2020)

RF18 | PSAT143 Brain Determinants of Dynamic Bone Remodeling in Females
por: Babey, Muriel, et al.
Publicado: (2022)

OR29-03 Social Isolation Stress Leads To Bone Loss In Adult Male, But Not Female, C57BL/6J Mice
por: Mountain, Rebecca, et al.
Publicado: (2023)

SUN-352 The Effects of Acute Hyponatremia on Bone Remodeling Markers in Patients with Subarachnoid Hemorrhage
por: Garrahy, Aoife, et al.
Publicado: (2020)

OR29-03 The Effects of Hormone Therapy on Premature Ovarian Failure Following Allogenic Hematopoietic Stem Cell Transplantation: A Single-Center Experience
por: Ha, Jeonghoon, et al.
Publicado: (2020)

OR29-05 Sarcopenia, Low Bone Mineral Density And Hidden Obesity In Young Adult Men Living With HIV (MLWH): Prevalence And Relationship With Sex Steroids
por: De Vincentis, Sara, et al.
Publicado: (2023)

OR29-01 Long-Term Safety in Adults with X-Linked Hypophosphatemia (XLH) Treated with Burosumab, a Fully Human Monoclonal Antibody Against FGF23: Final Results of a Phase 3 Trial
por: Perwad, Farzana, et al.
Publicado: (2020)

In Vivo Effects of Osteoblast-Specific Overexpression of Gα (s) and Gα (q/11) on Bone Formation and Bone Remodeling During Fracture Healing
por: Lee, Kathy Kyungeun, et al.
Publicado: (2021)

SAT-384 Identification of Heterozygous LRP5 Mutation and a TGFβ-1 Variant of Unknown Significance in a Patient with Hearing Loss, High Bone Mass, and Oropharyngeal Exostoses
por: Cheng, Cheng, et al.
Publicado: (2020)

Osteocyte-Specific TGFβ Signaling Mitigates Obesity-Induced Deregulated Energy Metabolism and Compromised Bone Quality
por: Dole, Neha S, et al.
Publicado: (2021)

SUN-LB72 The Relationship Between Estrogen Exposure and Bone Health in Women With Cystic Fibrosis
por: Arora, Neha, et al.
Publicado: (2020)

SAT-505 A Rare Case of Teriparatide Induced Persistent Hypercalcemia
por: Sistla, Divya, et al.
Publicado: (2019)

LBODP018 Hypercalcemia In A Child On Ketogenic Diet For Intractable Epilepsy
por: Gurnurkar, Shilpa, et al.
Publicado: (2022)

Glucocorticoid suppression of osteocyte perilacunar remodeling is associated with subchondral bone degeneration in osteonecrosis
por: Fowler, Tristan W., et al.
Publicado: (2017)

SAT-LB093 Salty Relationships with Bone: Not Calcium nor Vitamin D
por: Hew-Butler, Tamara, et al.
Publicado: (2019)

SAT-515 Racial-Ethnic Differences in Diabetes-Related Fracture Risk
por: Jain, Rajesh, et al.
Publicado: (2019)

SUN-380 Opportunistic Screening with Abdominal CT in Patients with Diabetes Can Identify Those at High Risk of Osteoporosis and Osteopenia
por: Jain, Rajesh, et al.
Publicado: (2020)

Sustained Morphine Delivery Suppresses Bone Formation and Alters Metabolic and Circulating miRNA Profiles in Mice
por: Carvalho, Adriana Lelis, et al.
Publicado: (2021)

Osteocyte Remodeling of the Perilacunar and Pericanalicular Matrix
por: Qing, Hai, et al.
Publicado: (2009)

OR30-1 Safety and Efficacy of Recombinant Human Parathyroid Hormone 1-84 for the Treatment of Adults with Chronic Hypoparathyroidism: Six-Year Results of the RACE Study
por: Bilezikian, John, et al.
Publicado: (2019)

OR21-1 The PaTH Forward Trial: Efficacy and Safety of TransCon PTH Through Week 84 for Adults With Hypoparathyroidism
por: Ahmed, Intekhab, et al.
Publicado: (2022)

SAT-LB72 Design of the PaTH Forward Phase 2 Trial of TransCon PTH, a Long-Acting PTH, in Patients With Hypoparathyroidism
por: Khan, Aliya Aziz, et al.
Publicado: (2020)

TransCon PTH as a Hormone Replacement Therapy for Patients with Hypoparathyroidism: 6-Month Update from the PaTH Forward Open-Label Extension
por: Rubin, Mishaela R, et al.
Publicado: (2021)

SAT-399 Baseline Characteristics from the Observational PARADIGHM Registry of Patients with Chronic Hypoparathyroidism
por: Clarke, Bart L, et al.
Publicado: (2020)

OR23-05 Log-term Efficacy And Safety Of Transcon PTH In Adults With Hypoparathyroidism: 52-week Results From The Open-label Extension Of The Phase 3 Pathway Trial
por: Clarke, Bart, et al.
Publicado: (2023)

SAT-510 Hypercalcemia Secondary to Vitamin D Intoxication and Nephrocalcinosis in 2 Children
por: Diaz, Alejandro, et al.
Publicado: (2019)

MON-519 Impact of Chronic Hypoparathyroidism on Work, Productivity, and Relationships: Findings from a 13-Country Patient and Caregiver Survey
por: Clarke, Bart, et al.
Publicado: (2019)

MON-518 Osteoporosis in a Young Adult with Trisomy 13
por: Wynn, Anne, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_91bq46tgmpv8ctjkoeiff4v9j2